NCT02271581
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Leo Jenkins Cancer Center Greenville, North Carolina, United States
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
440 public trials
56 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
NCT02519062
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milano, Italy
Completed
2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)
NCT00835471
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
- VU medisch centrum Amsterdam, Netherlands
- Rode Kruis Ziekenhuis Beverwijk, Netherlands
- Amphia Ziekenhuis Breda, Netherlands
NCT02671422
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- LK Krems Krems, Austria
- AKH - Medical University of Vienna Vienna, Austria
- Brussels - UNIV Saint-Luc Brussels, Belgium
- AZ Maria Middelares Ghent, Belgium
NCT02395172
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- University of Alabama Tuscaloosa, Alabama, United States
- Mayo Clinic Scottsdale , Phoenix, Arizona, United States
- Pacific Cancer Medical Center, Inc. Anaheim, California, United States
- Healing Hands Oncology and Medical Care Lawndale, California, United States
Completed
A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT02411591
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Charleroi, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Roeselare, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Brest, France
NCT01199055
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Samsung Medical Center Seoul, Gangnam-gu, South Korea
NCT03181308
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- University of Alabama, Birmingham Birmingham, Alabama, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT03134872
- Conditions
- Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tongji University, Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
NCT03761901
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Research Site Antwerp, Belgium
- Research Site Bouge, Belgium
- Research Site Brussels, Belgium
- Research Site Brussels, Belgium